Charles River Laboratories (CRL) Tops Q3 EPS by 6c, Updates Guidance

November 6, 2019 7:13 AM

Charles River Laboratories (NYSE: CRL) reported Q3 EPS of $1.69, $0.06 better than the analyst estimate of $1.63. Revenue for ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

No results found